BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14582458)

  • 1. FM-VP4 Forbes Medi-Tech.
    Burnett JR
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1120-5. PubMed ID: 14582458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JTT-705. Japan Tobacco.
    Linders JT
    Curr Opin Investig Drugs; 2004 Mar; 5(3):339-43. PubMed ID: 15083602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
    MMW Fortschr Med; 2005 Jul; 147(27-28):51. PubMed ID: 16041948
    [No Abstract]   [Full Text] [Related]  

  • 4. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease.
    Earnest CP; Mikus CR; Lemieux I; Arsenault BJ; Church TS
    Nutrition; 2007 Sep; 23(9):625-33. PubMed ID: 17644340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ezetimib and simvastatin. Cooperation at receptors of cholesterol metabolism].
    MMW Fortschr Med; 2005 Jul; 147(27-28):50. PubMed ID: 16041947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intestinal cholesterol absorption: a pharmacological target for lowering of plasma cholesterol].
    Catapano AL; Catapano L; Fellin R
    Ital Heart J Suppl; 2004 Oct; 5(10):779-84. PubMed ID: 15615349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options.
    Jones PH
    Am Heart J; 2004 Jul; 148(1 Suppl):S9-13. PubMed ID: 15211327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
    Looije NA; Risovic V; Stewart DJ; Debeyer D; Kutney J; Wasan KM
    J Pharm Pharm Sci; 2005 Aug; 8(3):400-8. PubMed ID: 16401390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].
    Rouffy J; Loeper J
    Therapie; 1972; 27(3):433-44. PubMed ID: 4570211
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on lipid-lowering therapy and LDL-cholesterol targets.
    Wiviott SD; Cannon CP
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):424-36. PubMed ID: 16874355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal.
    Clifton PM; Noakes M; Sullivan D; Erichsen N; Ross D; Annison G; Fassoulakis A; Cehun M; Nestel P
    Eur J Clin Nutr; 2004 Mar; 58(3):503-9. PubMed ID: 14985690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels.
    Polagruto JA; Wang-Polagruto JF; Braun MM; Lee L; Kwik-Uribe C; Keen CL
    J Am Diet Assoc; 2006 Nov; 106(11):1804-13. PubMed ID: 17081832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DX-9065a Daiichi.
    Kaiser B
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1105-12. PubMed ID: 14582456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plants sterols and stanols: new prospects in prevention of ischemic heart disease (based on data published in the European Heart Journal, 1999, vol. 1 (Suppl S))].
    Oganov RT; Kiseleva NG
    Ter Arkh; 2001; 73(1):33-8. PubMed ID: 11234137
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of hyperlipidemia and its treatment].
    Ouellet A
    Union Med Can; 1991; 120(3):238-43. PubMed ID: 1866844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study.
    Mannarino E; Pirro M; Cortese C; Lupattelli G; Siepi D; Mezzetti A; Bertolini S; Parillo M; Fellin R; Pujia A; Averna M; Nicolle C; Notarbartolo A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):84-90. PubMed ID: 18762410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.